Advanced imaging technology detects undiagnosed metastases in high-risk prostate cancer

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Almirall and Absci partner to develop AI-designed therapeutics for dermatological diseases

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, and Absci Corporation, a generative AI drug creation company, today announced a drug discovery partnership aimed to

November 20, 2023

Sly CAR-T strategy evades ‘fratricide’ problem to aim at all blood cancers

The problem with the plan was fratricide, among other wanton cellular murders. Saar Gill and Carl June, cell therapy researchers at the University of Pennsylvania,

August 31, 2023

UK medical research group reveals £100M rare diseases program; Allarity announces $11M offering

UK non-profit and medical research group LifeArc is looking to push further into rare disease research, so it has created a “challenge” to try and

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.